Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.WT

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by bartlmanon Oct 18, 2018 12:22am

87 Views

Post# 28824712

RE:Future JVs

Nice post John and R. I like your line of thinking. Yes, TLT casts a wide umbrella for sure - so many applications. Whoever gobbles up this company will hopefully have the resources to bring these various applications to fruition and dominate a significant percentage of the broader health care market. Potentially bigger than Amazon. Or, at least, the Amazon of healthcare.

Bullboard Posts

Sparta and Parametric join forces to advance autonomous medicine project